CD4 and renal cell carcinoma: In patients with posterior uveal melanoma [125], pancreatic carcinoma [123], osteosarcoma, HCC, and RCC [126] that were treated with HIFU, increased percentages of CD4+ T cells and a higher CD4+/CD8+ ratio were observed [125, 126].